Preservation of fertility in patients with cancer

New England Journal of Medicine

Volumn 360, Issue 25, 2009, Pages 2682-

  Meirow, Dror ^a   Wallace, W Hamish ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CRYOPRESERVATION; FEMALE FERTILITY; HUMAN; LETTER; LEUKEMIA; NEOPLASM; OOCYTE MATURATION; OVARY INSUFFICIENCY; PRIORITY JOURNAL;

CHILD; CRYOPRESERVATION; FEMALE; FERTILITY; HUMANS; NEOPLASMS; OVARIAN FAILURE, PREMATURE; OVARY;

EID: 67449128227     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young people with cancer: who is at risk and what can be offered? Lancet Oncol 2005;6:209-218 [Erratum, Lancet Oncol 2005;6:922.]
2. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age at ovarian failure following radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005;62:738-744 (Pubitemid 40779763)
3. Meirow D, Levron J, Eldar-Geva T, et al. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril 2007;87(2):418.e7-418.e15. (Pubitemid 46188445)
4. Meirow D, Schiff E. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. In: Parenthood after cancer: today's options and tomorrow's hopes. Journal of the National Cancer Institute monographs. No. 34. Bethesda, MD: Journal of the National Cancer Institute, 2005:21-25
5. Meirow D, Hardan I, Dor J, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008;23:1007-1013 (Pubitemid 351757322)